Over the last 10 years, advances in the treatment of acute lung injury and
the adult respiratory distress syndrome have affected the survival from thi
s disease process. This improvement has occurred, in part, because of an im
proved understanding of the pathophysiology of lung failure. Other advances
in critical care-improved antibiotics, ventilators, and diagnostic and the
rapeutic techniques-also have contributed to this improvement. "Cutting-edg
e" technologic advances for the treatment of respiratory failure are presen
ted in this article as alternative therapeutic modalities available to almo
st every intensivist today.